Lanreotide Acetate 76282-0719

Product NDC

76282-0719

Manufacturer: Exelan Pharmaceuticals, Inc.
Dosage Form: Injection
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: May 30, 2025
Listing Expires: December 31, 2026
Application: ANDA217193

Need to source Lanreotide Acetate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lanreotide Acetate	90 mg/.3mL

Drug Class

Somatostatin Analog [EPC]Somatostatin Receptor Agonists [MoA]

Packaging Options(1)

76282-0719-67

1 POUCH in 1 CARTON (76282-719-67) / 1 SYRINGE in 1 POUCH / .3 mL in 1 SYRINGE

View →